For the purpose of designing the patient-based model for Dementia with Lewy Bodies (DLB), the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of ...

Audio pioneer Dolby Laboratories (DLB) has made significant strides recently. The company has partnered with brands such as ...

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participants who have received capsules from a more recently ma ...

We are neutral on Dolby Labs due to limited upside potential despite revenue growth and strong balance sheet in FQ1 2025. Read an analysis of DLB stock here.

Q1 2025 Earnings Call Transcript January 29, 2025 Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.14 ...

The Lady Lakers hosted the South Prairie-Max Royals at the dock for some region 3 basketball action. The Royals held a 17 ...

About Dementia with Lewy Bodies (DLB) DLB is the third most common degenerative disease of the brain (after Alzheimer’s disease and Parkinson’s disease), with approximately 700,000 individuals ...

Investors often focus myopically on earnings, but a company's balance sheet — its financial strength, is also key.

Dolby Laboratories Inc (DLB) reports a 13% revenue increase, fueled by robust licensing performance and expanding automotive ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time scorecard for the Q4 earnings season and new research reports on 16 major ...